These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34270462)

  • 21. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 23. FXYD proteins as regulators of the Na,K-ATPase in the kidney.
    Sweadner KJ; Arystarkhova E; Donnet C; Wetzel RK
    Ann N Y Acad Sci; 2003 Apr; 986():382-7. PubMed ID: 12763854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FXYD7, mapping of functional sites involved in endoplasmic reticulum export, association with and regulation of Na,K-ATPase.
    Crambert G; Li C; Swee LK; Geering K
    J Biol Chem; 2004 Jul; 279(29):30888-95. PubMed ID: 15133029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of gene and protein structures in the FXYD family proteins.
    Franzin CM; Yu J; Thai K; Choi J; Marassi FM
    J Mol Biol; 2005 Dec; 354(4):743-50. PubMed ID: 16288923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Displacement of Native FXYD Protein From Na
    Liu CC; Kim YJ; Teh R; Garcia A; Hamilton EJ; Cornelius F; Baxter RC; Rasmussen HH
    Front Oncol; 2022; 12():859216. PubMed ID: 35371992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
    Yang X; Su X; Wang Z; Yu Y; Wu Z; Zhang D
    Mol Cell Biochem; 2023 Oct; 478(10):2207-2219. PubMed ID: 36633827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.
    Moshitzky S; Asher C; Garty H
    J Biol Chem; 2012 Jun; 287(25):21130-41. PubMed ID: 22535957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
    Liang Y; Zhang C; Dai DQ
    World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.
    Luo D; Shan Z; Liu Q; Cai S; Li Q; Li X
    Biomed Res Int; 2020; 2020():4845360. PubMed ID: 33282950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase.
    Crambert G; Geering K
    Sci STKE; 2003 Jan; 2003(166):RE1. PubMed ID: 12538882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.